The molecular pathogenesis of HIV-1 associated nephropathy: recent advances (Q37827370)

23 August 2017

1 reference

title

The molecular pathogenesis of HIV-1 associated nephropathy: recent advances (English)

1 reference

23 August 2017

0 references

0 references

1 reference

4

Robert Kalyesubula

0 references

Krzysztof Kiryluk

series ordinal

3

object named as

Krzysztof Kiryluk

1 reference

23 August 2017

Natalia Papeta

1

1 reference

PubMed ID

21221512

23 August 2017

Roel Sterken

series ordinal

2

1 reference

PubMed ID

21221512

23 August 2017

Ali G Gharavi

series ordinal

5

1 reference

23 August 2017

11 January 2011

1 reference

Journal of Molecular Medicine

23 August 2017

1 reference

23 August 2017

89

1 reference

23 August 2017

5

1 reference

23 August 2017

429-436

1 reference

https://scigraph.springernature.com/pub.10.1007/s00109-010-0719-x

23 August 2017

0 references

cites work

Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

The impact of kidney function at highly active antiretroviral therapy initiation on mortality in HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

HIV-associated nephropathy in the era of antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

HIV and kidney disease in sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

Highly active antiretroviral therapy and the epidemic of HIV+ end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

Controversies in the pathogenesis of HIV-associated renal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

Pathologic classification of focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

Mapping a locus for susceptibility to HIV-1-associated nephropathy to mouse chromosome 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

HIV-1 Nef induces dedifferentiation of podocytes in vivo: a characteristic feature of HIVAN

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

HIV-1 Nef disrupts the podocyte actin cytoskeleton by interacting with diaphanous interacting protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

Podocytes in HIV-associated nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

Critical role for Nef in HIV-1–induced podocyte dedifferentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

Persistent NF-kappaB activation in renal epithelial cells in a mouse model of HIV-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

NF-kappaB regulates Fas-mediated apoptosis in HIV-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

HIVAN phenotype: consequence of epithelial mesenchymal transdifferentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

Antiretroviral therapy improves renal function among HIV-infected Ugandans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

Decreased kidney function in a community-based cohort of HIV-Infected and HIV-negative individuals in Rakai, Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

HIV-infected persons continue to lose kidney function despite successful antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

Contrasting Genetic Influence of CCR2 and CCR5 Variants on HIV-1 Infection and Disease Progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

MYH9 is associated with nondiabetic end-stage renal disease in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

Association of trypanolytic ApoL1 variants with kidney disease in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

Urinary NGAL marks cystic disease in HIV-associated nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

Susceptibility loci for murine HIV-associated nephropathy encode trans-regulators of podocyte gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

Accelerated development of collapsing glomerulopathy in mice congenic for the HIVAN1 locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

A susceptibility gene for kidney disease in an obese mouse model of type II diabetes maps to chromosome 8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

Genetic dissection of transcriptional regulation in budding yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

Genetics of gene expression surveyed in maize, mouse and man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

Genetics of global gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

Jund is a determinant of macrophage activation and is associated with glomerulonephritis susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

An integrative genomics approach to infer causal associations between gene expression and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

Variations in DNA elucidate molecular networks that cause disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

Genetics of gene expression and its effect on disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

Integrating genetic and network analysis to characterize genes related to mouse weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

Bigenic mouse models of focal segmental glomerulosclerosis involving pairwise interaction of CD2AP, Fyn, and synaptopodin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

Reverse engineering of regulatory networks in human B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

Systems genetics of complex traits in Drosophila melanogaster

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

Revealing modularity and organization in the yeast molecular network by integrated analysis of highly heterogeneous genomewide data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

Integrative analysis for finding genes and networks involved in diabetes and other complex diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

Expression profiling of human genetic and protein interaction networks in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0719-X

Renal epithelium is a previously unrecognized site of HIV-1 infection.

21 January 2018

1 reference

12 December 2020

Prevalence of HIV-associated nephropathy in autopsies of HIV-infected patients

1 reference

12 December 2020

Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection

1 reference

12 December 2020

Trends in diseases reported on U.S. death certificates that mentioned HIV infection, 1987-1999

1 reference

12 December 2020

Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy

1 reference

12 December 2020

Amelioration of nephropathy in mice expressing HIV-1 genes by the cyclin-dependent kinase inhibitor flavopiridol

1 reference

12 December 2020

The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy

1 reference

12 December 2020

HIV-associated nephropathy in transgenic mice expressing HIV-1 genes

1 reference

12 December 2020

Collapsing glomerulopathy

1 reference

12 December 2020

HIV infection changes glomerular podocyte cytoskeletal composition and results in distinct cellular mechanical properties

1 reference

12 December 2020

Mapping by admixture linkage disequilibrium in human populations: limits and guidelines

1 reference

12 December 2020

Risk factors for the development of chronic kidney disease with HIV/AIDS.

1 reference

12 December 2020

Suppression of HIV-1 expression by inhibitors of cyclin-dependent kinases promotes differentiation of infected podocytes

1 reference

12 December 2020

Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways

1 reference

12 December 2020

10.1007/S00109-010-0719-X

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

21221512